Vireo Growth Inc.

Vireo Growth Inc. is a U.S.-based cannabis company brand operating in the regulated state-legal cannabis sector. The company is associated with the Vireo Health family of businesses, which built its position around cultivation, extraction, processing and branded consumer cannabis products, together with retail dispensary operations in states where medical and adult-use cannabis are licensed. The brand's commercial model is vertically integrated in the markets it serves: it develops and produces cannabis flower, concentrates, vapes and other derivative products under its own labels, and distributes them through its own licensed dispensaries as well as wholesale channels to third-party retailers. This structure lets the company control product quality and capture margin across the supply chain, a common approach among U.S. multi-state cannabis operators. Vireo Growth Inc. is a publicly traded corporate brand, with its shares historically associated with the over-the-counter and Canadian-listed cannabis equity universe before the company's rebranding and corporate reorganization under the Vireo Growth name. Its investor profile is typical of U.S. plant-touching cannabis companies: capital raised through public equity markets, exposure to state-by-state licensing regimes, and sensitivity to federal cannabis policy and tax treatment. Positioning-wise, the brand presents itself as a science-driven, quality-focused cannabis producer, emphasizing pharmaceutical-grade standards inherited from its medical cannabis origins while expanding into adult-use recreational markets. Its portfolio spans medical patients and recreational consumers, with brand architecture built around product categories rather than a single flagship SKU. Note: the supplied evidence snippets do not contain material about Vireo Growth Inc.; they concern unrelated consumer-electronics and e-commerce topics. This dossier therefore relies on well-established public facts about the company and should be verified against primary sources before publication.

Vireo Growth Inc. traces its origins to the Vireo Health group, a U.S. cannabis company founded by physician-entrepreneurs who positioned the business around medical cannabis and pharmaceutical-style production standards. Vireo Health obtained one of the early medical cannabis manufacturing licenses in Minnesota and built cultivation and processing capacity there before expanding into additional states with medical and, later, adult-use programs. Through the mid-2010s the company expanded its footprint through license applications and acquisitions in states such as New York, Pennsylvania, Maryland, Arizona, New Mexico and Rhode Island, assembling a multi-state operating platform. Its product strategy centered on branded cannabis flower, concentrates and vaporization products, supported by in-house extraction and formulation capabilities. Vireo Health became a publicly traded company, with its shares quoted on the over-the-counter market in the United States and listed on the Canadian Securities Exchange — a common path for U.S. plant-touching cannabis businesses barred from major U.S. exchanges. The company used public equity raises to fund build-outs of cultivation facilities and dispensary networks. In the 2020s the company undertook a corporate rebranding to Vireo Growth Inc., reflecting a strategic emphasis on growth markets, retail expansion and balance-sheet restructuring. The rebrand accompanied efforts to streamline operations, divest non-core assets and focus capital on states with favorable licensing and demand dynamics. Like many U.S. cannabis operators, Vireo Growth has navigated a difficult operating environment marked by price compression in wholesale cannabis, high effective tax burdens under U.S. tax rules, limited access to banking, and volatile capital markets. Its history is therefore one of license-driven expansion punctuated by portfolio rationalization and repeated recapitalization. Note: the supplied evidence snippets contain no information about Vireo Growth Inc.; they discuss Samsung image sensors and Chinese e-commerce. The history above is drawn from well-established public facts and should be verified against primary filings before publication.

• Vireo Health obtains an early medical cannabis manufacturing license in Minnesota and begins cultivation and processing operations.

• Company expands into additional states including New York, Pennsylvania, Maryland, Arizona, New Mexico and Rhode Island.

• Vireo Health becomes publicly traded, quoted over-the-counter in the U.S. and listed on the Canadian Securities Exchange.

• Corporate rebranding to Vireo Growth Inc., emphasizing growth markets and retail expansion.

Science-driven, quality-focused licensed cannabis producer and retailer serving medical and adult-use markets in the United States.

• Cannabis flower

  Dried cannabis flower sold under company brands to medical patients and adult-use consumers.

• Cannabis concentrates

  Extracted cannabis concentrates produced in-house for retail and wholesale distribution.

• Vaporization products

  Cannabis oil vaporization cartridges and related devices.

1. 1Vireo Growth Inc. (company information)vireogrowth.com
2. 2Vireo Growth Inc.: Vireo Growth Receives Regulatory Approval and Completes Acquisition of PharmaCann Colorado Retail Assetsfinanznachrichten.de
3. 3Vireo Growth Receives Regulatory Approval and Completes Acquisition of PharmaCann Colorado Retail Assetsleaderpost.com